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httpStaged endovascular repair of thoracoabdominal
aortic aneurysms limits incidence and severity of
spinal cord ischemia
Adrian O’Callaghan, MD, Tara M. Mastracci, MD, and Matthew J. Eagleton, MD, Cleveland, Ohio
Objective: Neurologic dysfunction remains a persistent complication of extensive aortic repair owing to disruption of the
spinal collateral network. We hypothesized that staged repair might mitigate the incidence and severity of this spinal cord
ischemia (SCI).
Methods: We conducted a retrospective cohort study of patients undergoing a Crawford type II repair of a thor-
acoabdominal aortic aneurysm between January 2008 and July 2013. Baseline demographics, incidence of prior aortic
surgery, comorbidities, and outcomes were prospectively recorded. Staged repair was deﬁned as intentional completion of
the endovascular repair as two temporally separate procedures, referred to as a two-stage repair. Extent of aortic cover was
calculated by three-dimensional imaging and reported as the proportion of the aorta covered between the left subclavian
artery and the aortic bifurcation. Primary outcome measures were incidence and severity of SCI and mortality.
Results: The study included 87 patients, divided into the following subgroups: single-stage repair (n [ 32; repair in a
single procedure, without prior aortic surgery), two-stage repair (n [ 27; repair in two separate procedures, without
prior aortic surgery), and unintentionally staged repair (n[ 28; those with prior aortic surgery, without an intention to
stage). Median time between stages was 5 months (range, 1-60 months). All groups were equivalent in terms of de-
mographics and risk factors; however, the staged group had signiﬁcantly greater proximal aortic cover (P [ .001). The
overall rates of SCI in the nonstaged and staged groups were 37.5% (12 of 32) and 11.1% (3 of 27), respectively (P [
.03). Furthermore, all neurologic injuries in the staged group were temporary. The 30-day survival in the single-stage,
two-stage, and unintentionally staged repairs was 18.8%, 0%, and 10.7%, respectively (P [ .52).
Conclusions: Staged repair appears both to protect against SCI and to enhance overall survival in extensive aortic
repair. (J Vasc Surg 2015;61:347-54.)Open surgical thoracoabdominal aortic aneurysm
(TAAA) repair offers patients a durable solution for this
devastating disease, provided they can tolerate the morbid
procedure. Initial reports of the successful repair of TAAA
were soon followed by the recognition that such extensive
surgery was associated with an increased incidence of post-
operative neurologic dysfunction.1,2 Over time, the develop-
ment of protective measures, such as moderate hypothermia,
distal bypass, and spinal drainage, mitigated these effects in
part. However, maintenance of spinal perfusion, in the
form of intercostal reimplantation, has been shown to be a
powerful determinant of a positive outcome.3,4the Department of Vascular Surgery, Cleveland Clinic.
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a therapeutic solution.5 The absence of aortic cross-
clamping and the avoidance of a thoracotomy, among other
beneﬁts, conspire to lessen the insult associated with open
repair. However, despite these advances, the incidence of
postoperative neurologic dysfunction remains stubbornly
high. Rates of spinal cord ischemia (SCI) after endovascular
repair of TAAA have been reported as high as 20%.6 Device
length, extent of aneurysm repaired, and occlusion of spinal
collaterals such as the left subclavian artery or hypogastric ar-
tery were shown to be important contributors to the devel-
opment of postoperative spinal dysfunction and clinical
outcomes.7,8 In spite of the many beneﬁts of endovascular
surgery, options are limited with regard to maintenance of
perfusion of any excluded intercostal or lumbar vessels.
A combination of clinical and experimental work in the
last decade has served to further elucidate the spinal perfu-
sion network and the relative importance of the different
contributors. What has emerged is the concept of a collat-
eral network that can potentially lessen the impact of spinal
ischemia if it is optimized.9 This collateral network may
behave in a compensatory manner, similar to other vascular
beds, and maintain perfusion pressures when contributors
are excluded. Separating the ischemic insult into two lesser
procedures may facilitate the remaining perfusing elements
to compensate and so maintain function. We hypothesized
that staging of extensive thoracoabdominal repairs in this347
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ischemia. The aim of this investigation was to evaluate
the outcomes for patients undergoing endovascular
TAAA repair, comparing outcomes between those who
were repaired at one setting and those who were repaired
in a staged fashion.
METHODS
A retrospective cohort study of patients undergoing
endovascular repair of a Crawford type II TAAA between
January 2008 and July 2013 was performed. This analysis
represents a subset of patients who underwent a fenestrated
or branched repair of a TAAA between 2001 and the pre-
sent and are maintained in a prospective database as part of
a physician-sponsored Investigational Devices Exemption
trial (NCT00583050). The constituent patients have
been well described previously but brieﬂy include those
who, by virtue of their comorbid conditions, are consid-
ered at high risk for conventional repair.10 Recorded vari-
ables include clinical, operative, and imaging data for
each patient as well as outcomes and any secondary inter-
ventions performed. Operative strategy was recorded with
regard to those who underwent either primary repair or
repair in a staged fashion. After device implantation, pa-
tients were physically evaluated and imaged at 1 month
and 6 months and thereafter at yearly intervals. Informed
consent was obtained from each patient before surgery,
and the trial was approved by the Cleveland Clinic Institu-
tional Review Board (IRB #12-994).
The default strategy for total endovascular repair of
TAAA disease was stent insertion and achievement of aneu-
rysmal exclusion in a single procedure. It was the recogni-
tion that extensive aortic cover exacerbated the risk of
postoperative paraplegia that led to the decision to begin
staging of endovascular TAAA in an effort to decrease
the insult and to give the spinal perfusion network an op-
portunity to collateralize. Patients who were staged fell
into two separate categories, those who were intentionally
staged (two-stage repair) and those who had prior aortic
repair (unintentional staging). Intentional staging of the
procedure was performed by initial placement of a thoracic
aortic endograft, covering the aorta from the proximal seal
zone to just above the level of the most proximal visceral
branch vessel to be incorporated in the fenestrated or
branched repair. Repair in this manner leads to a type Ib
endoleak, which is then excluded after insertion of the
visceral segment device following an interval of approxi-
mately 2 to 3 months (this represents the ideal; in practice,
the interval is often longer because of scheduling difﬁculties
or the patient’s preference). The aorta was deﬁned as that
segment from the left subclavian origin to the aortic bifur-
cation; therefore, elephant trunk grafts performed for
concomitant arch disease were not considered as a staged
aortic repair in this study. For the purposes of this paper,
staged repair refers to an operative strategy as outlined
before; single-stage repair describes the complete aneu-
rysmal exclusion with a fenestrated or branched endograft
at one single, operative time point.The decision to offer an individual patient a staged
repair was at the discretion of the operating surgeon. How-
ever, the trend in recent years has been to stage the major-
ity of the type II repairs. Few type III repairs and no type I
or IV repairs were staged, and consequently those repairs
have been excluded from this analysis. It has always been
our practice to categorize patients on the basis of the repair
rather than the aneurysm; thus, a proportion of the type II
patients would have had type III aneurysms but required
aortic cover above T6 to achieve a durable repair.
The steps involved in device selection and insertion have
been described previously.10 The tenants of multimodal
optimization were used to maximize spinal perfusion.
Brieﬂy, this consisted of maintenance of a postoperative
mean arterial pressure above 85 mm Hg, avoidance of ﬂuid
overload, and perioperative use of a spinal drain to minimize
intrathecal pressures as previously described.5,8
SCI was deﬁned as an objective deterioration in motor
function in the postoperative period before discharge (no
patient was admitted after discharge with a new loss of
function attributable to the repair). Patients were examined
at least twice daily by a member of the clinical team and
more frequently if indicated. All complications were
recorded prospectively by a research nurse on a standard-
ized pro forma. Imaging conﬁrmation of a spinal infarct
was not used to make the diagnosis; however, any new inci-
dent of neurologic dysfunction was investigated with a
computed tomography (CT) brain scan to exclude intrace-
rebral hemorrhage as a contributor. SCI was scored on a 3-
point scale (Supplementary Table, online only) and
described as permanent or temporary (temporary deﬁned
as improvement of one full grade before discharge) and
in terms of timing at onset (immediate, in the ﬁrst 24 hours,
or delayed, thereafter). The primary outcome measure was
the incidence of spinal ischemia. Secondary outcomes
included the severity and duration of any neurologic
dysfunction suffered, cardiorespiratory and renal morbidity,
and both 30-day and overall mortality.
Clinical information, inclusive of baseline demo-
graphics, comorbid conditions, and outcomes, was recorded
for each patient. Of particular interest was the prevalence of
prior aortic surgery, as we hypothesized that this may func-
tion as a type of unintentional staging. Therefore, patients
were stratiﬁed both by repair type and by the presence of
prior aortic repair (deﬁned, as before, as open or endovascu-
lar aortic replacement between the left subclavian artery and
aortic bifurcation). Operative factors, such as procedural
time, ﬂuoroscopy time, volume of contrast material, and
procedural success, were also noted. Preoperative and post-
operative CT angiography was used to calculate the propor-
tion of aorta covered by the device, and this measurement
was then used along with the Crawford classiﬁcation as a
descriptor. Arterial contrast CT imaging was imported
onto a three-dimensional workstation (TeraRecon, San
Mateo, Calif) and a semiautomated centerline of ﬂow
created. All imaging analysis and measurements were per-
formed on this workstation. The log-rank test (Mantel-
Cox) was used to compare survival data. Student t-test
Table I. Demographics and comorbidity proﬁle
Factor
Total
(N ¼ 87)
Single-stage
repair (n ¼ 32)
Two-stage
repair (n ¼ 27)
Unintentionally staged
repair (n ¼ 28) P value
Sex 51 (58.6) 20 (62.5) 12 (44.4) 19 (67.9) .18a
Age at ﬁrst implant 71.9 6 7.2 72.5 6 7.2 69.9 6 6.3 73.3 6 7.9 .18b
Family history 19 (21.8) 6 (18.8) 4 (14.8) 9 (32.1) .26a
ASA grade 4 40 (46.0) 16 (50.0) 11 (40.7) 13 (46.4) .78a
Diabetes 13 (14.9) 6 (18.8) 4 (14.8) 3 (10.7) .65c
Hyperlipidemia 55 (63.2) 18 (56.3) 21 (77.8) 16 (57.1) .17a
HTN 77 (88.5) 28 (87.5) 26 (96.3) 23 (82.1) .25c
MI 15 (17.2) 4 (12.5) 3 (11.1) 8 (28.6) .15a
CRI 12 (13.8) 4 (12.5) 2 (7.4) 6 (21.4) .34c
COPD 27 (31.0) 9 (28.1) 10 (37.0) 8 (28.6) .72a
Smoking 75 (86.2) 25 (78.1) 24 (88.9) 26 (92.9) .24c
ASA, American Society of Anesthesiologists; COPD, chronic obstructive pulmonary disease; CRI, chronic renal insufﬁciency; HTN, hypertension;
MI, myocardial infarction.
Values presented as mean 6 standard deviation or number (%).
aPearson c2 test.
bAnalysis of variance.
cFisher exact test.
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analyze continuous and categorical data, respectively.
RESULTS
In the 66-month period between January 2008 and the
end of June 2013, 574 patients underwent fenestrated or
branched endovascular repair. Of these, 95 (16.6%) were
Crawford type II procedures. After the exclusion of three pa-
tients who underwent emergency repairs and ﬁve patients
who had staged repairs as well as prior aortic surgery (and
were thus excluded because they were too small a group to
analyze separately), the patients were divided into the
following subgroups: single-stage repair (n ¼ 32); two-stage
repair (n ¼ 27); and unintentionally staged repair (n ¼ 28).
Six of the unintentionally staged group had undergone prior
thoracic repair, the remainder abdominal aortic replacement.
There were no differences between the groups in terms of
baseline demographics or comorbidity proﬁle (Table I). The
two-stage repair group had a signiﬁcantly greater proportion
of the aorta covered than the other groups did, therefore
conferring a higher risk of SCIda mean of 94% covered in
the two-stage group (standard deviation of 8) and 87% in
the single-stage group (standarddeviationof12) (P¼ .0121).
The median time between two-stage cases was 5 months
(range, 1-60 months), and that between unintentionally
staged repairs was 102 months (range, 12-348 months).
The single complication after the ﬁrst stage (in the two-
stage repair group) was a case of transient lower limb weak-
ness, which resolved completely before discharge. No
patient declined to return for the second (completion)
stage; however, one patient ruptured 2 months after the
thoracic stent and subsequently underwent a successful
open repair, followed by completion fenestrated endovascu-
lar aortic aneurysm repair 3 months later.
Spinal ischemia. The outcomes for type II repairs are
shown in Tables II and III. The risk of SCI was highest in
the single-stage group, with 12 of 32 patients (37.5%)experiencing some form of neurologic injury. Seven of the
12 patients affected (58%) demonstrated an improvement
before discharge. In contrast, only three (11.1%) two-stage
repairs suffered SCI, all of which resolved completely before
discharge. A similar protective effect occurred in uninten-
tionally staged type II repairs, with four of 28 (14.3%)
developing symptoms of SCI (P ¼ .025). In addition to the
lower incidence of spinal ischemia in the two-stage group
and the transient nature of any dysfunction, there also
appeared to be a protective effect of staging in terms of the
severity of the injury (Table II). All of the cases of neuro-
logic dysfunction in the two-stage group were of weakness
only, none with complete paralysis (P ¼ .025).
Mortality. The 30-day mortality is shown in Table III,
with rates in the two-stage, single-stage, and unintention-
ally staged groups of 0%, 18.8%, and 10.7% respectively
(P ¼ .052). This trend toward improved 30-day survival in
the two-stage group was reﬂected in the overall survival
(shown in the Fig), with signiﬁcantly improved outcomes
in the two-stage repair group. A similar survival beneﬁt is
seen in those with prior aortic surgery.
DISCUSSION
Early reports of successful thoracoabdominal aneurysm
repair were tempered by the recognition that postoperative
neurologic dysfunction occurred in proportion to the extent
of aortic replacement.11 The demonstration that intercostal
vessel reimplantation lessened the incidence of injury evi-
denced the critical role of spinal perfusion.12 In spite of its
minimally invasive approach and absence of organ ischemia,
endovascular repair suffers particularly from its inability to
maintain perfusion to the intercostal/lumbar collaterals.
Two endovascular approaches to correct this deﬁcit have
been described; Reilly et al reported a single case of success-
ful creation of a type Ib endoleak to perfuse the lumbar ves-
sels following the development of paraplegia after a type II
repair.13 The endoleak, created by the chimney stent
Table II. Development of spinal cord ischemia (SCI)
Factor
Total
(N ¼ 87), No. (%)
Single-stage repair
(n ¼ 32), No. (%)
Two-stage repair
(n ¼ 27), No. (%)
Unintentionally staged repair
(n ¼ 28), No. (%) P value
SCI 19 (21.8) 12 (37.5) 3 (11.1) 4 (14.3) .025c
Time to development of SCI .13a
None 68 (78.2) 20 (62.5) 24 (88.9) 24 (85.7)
Immediate 9 (10.3) 5 (15.6) 2 (7.4) 2 (7.1)
Delayed 10 (11.5) 7 (21.9) 1 (3.7) 2 (7.1)
Duration of SCI .033a
None 68 (78.2) 20 (62.5) 24 (88.9) 24 (85.7)
Improved 11 (12.6) 7 (21.9) 3 (11.1) 1 (3.6)
Permanent 8 (9.2) 5 (15.6) 0 (0.0) 3 (10.7)
SCI severity score .025a
None 68 (78.2) 20 (62.5)b 24 (88.9)c 24 (85.7)
Weakness 8 (9.2) 5 (15.6) 2 (7.4) 1 (3.6)
No antigravity 2 (2.3) 0 (0.0) 1 (3.7) 1 (3.6)
Complete paralysis 9 (10.3) 7 (21.9) 0 (0.0) 2 (7.1)
A signiﬁcance level of .017 was used for pairwise ad hoc comparisons.
aFisher exact test.
bSigniﬁcantly different from two-stage repair.
cSigniﬁcantly different from single-stage repair.
Table III. Outcome results
Factor
Total
(N ¼ 87), No. (%)
Single-stage repair
(n ¼ 32), No. (%)
Two-stage repair
(n ¼ 27), No. (%)
Unintentionally staged repair
(n ¼ 28), No. (%) P value
SCI 19 (21.8) 12 (37.5) 3 (11.1) 4 (14.3) .025a
Duration of SCI .033b
None 68 (78.2) 20 (62.5) 24 (88.9) 24 (85.7)
Improved 11 (12.6) 7 (21.9) 3 (11.1) 1 (3.6)
Permanent 8 (9.2) 5 (15.6) 0 (0.0) 3 (10.7)
30-day mortality 9 (10.3) 6 (18.8) 0 (0.0) 3 (10.7) .052b
Prolonged intubation (FEVAR) 13 (14.9) 7 (21.9) 1 (3.7) 5 (17.9) .11b
Tracheostomy (FEVAR) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Dialysis (FEVAR) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
AKI (FEVAR) 12 (13.8) 7 (21.9) 2 (7.4) 3 (10.7) .26b
MI (FEVAR) 5 (5.7) 2 (6.3) 1 (3.7) 2 (7.1) .99b
AKI, Acute kidney injury; FEVAR, fenestrated endovascular aortic aneurysm repair; MI, myocardial infarction; SCI, spinal cord ischemia.
A signiﬁcance level of .017 was used for pairwise ad hoc comparisons.
aPearson c2 test.
bFisher exact test.
JOURNAL OF VASCULAR SURGERY
350 O’Callaghan et al February 2015technique to break the distal endoseal (in aortic zone 9), was
then sealed at a later interval. This solution, although suc-
cessfully applied in that case, is likely to be suitable only to
those situations in which the distal seal is above the aortic
bifurcation, threatens the durability of the repair, and further
suffers from its reactive nature to spinal ischemia. The second
technique, developed by Ivanchev et al,14 incorporates spinal
perfusion branches in the endograft design. These branches
are then sealed at a later interval, after recovery from the in-
dex procedure. This innovation, although successfully
applied in a series of 10 patients, still resulted in an overall
neurologic injury rate of 30%, a rate comparable to that of
conventional endovascular reports in the literature. Its failure
in this regard may be explained by the fact that there is no
way of knowing how much of the spinal cord is perfused
by those branches; therefore, the initial stress may not be
enough to stimulate the collateralization response.The staged approach to extensive aneurysm repair is
predicated on the extensive collateral network supplying
the spinal cord.15 Experimental work, further evidenced in
clinical series, has characterized the functional elements of
this network: that the spinal cord can tolerate the loss of
some contributors to perfusion (but a tipping point is
reached beyond which dysfunction is inevitable), that back-
ﬂow from intercostals or lumbars leads to a steal phenome-
non (and is controlled for by temporary balloon occlusion
during open repair), and that not all collateral sources are
created equally (reafﬁrming the relative dominance of the
distal intercostals as ﬁrst described by Adamkiewicz).16-18
Furthermore, Etz et al9 have demonstrated the remodeling
that occurs after the loss of elements of the collateral supply.
Staged repair builds on this concept of a collateral supply,
through the completion of the repair in two temporally sepa-
rate procedures in an effort to maximize collateralization.
Fig. Kaplan-Meier survival curve.
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mental work to evidence this concept was published in
2011 and demonstrates that staged exclusion of intercostal
and lumbar vessels (with a 7-day separation interval) results
in statistically signiﬁcant improved scores of both neurologic
injury and histopathologic cord damage.19
Clinical experience with staging is limited. Etz et al20
reported on their experience with 35 patients who under-
went thoracic repair and after a median interval of 5 years
had a type III/IV repair, the staging in this case likely be-
ing unintentional and reﬂecting disease progression. None-
theless, the rate of permanent neurologic injury was 0% in
the “staged” group compared with 15% in the single type
II procedure group. The application of thoracic stenting
to supplement open surgical repair of the visceral segment
in type II and type III aortic disease, hybrid surgery, lends
itself well to a staged approach. Individual small-scale series
have provided encouraging results; however, a meta-
analysis failed to detect a statistically signiﬁcant beneﬁt to
staging.21 This may be explained by the heterogeneity of
individual series and the differing risks imposed by a history
of prior aortic surgery or dissection.
Our experience, described before, represents the largest
series of staged repairs reported in the literature. It is clear
from examining the cumulative experience with open repair
that aneurysm extent is not the only inﬂuencer of outcome.
Although reports differ as to its precise effect, the presence
of prior aortic surgery clearly is a factor to be considered in
terms of the risks of spinal ischemia.5,20 Previous aortic
repair, open or endovascular, results in collateral occlusion,
thereby challenging the network, and likely represents de
facto staging. For this reason, we elected to ﬁlter out those
who had past aortic intervention and to consider them as a
separate group (crucially, we believe that the patients should
be grouped in terms of the overall repair, not just the most
recent, which may account for the differential reports on the
impact of prior aortic surgery). The lesser incidence of SCI
in the prior surgery cohort, as with staging, would appear to
support this hypothesis. Prior surgery has almost certainly
stimulated a collateralization response in the past, and webelieve that further staging in this group adds little beneﬁt
as one would be either covering an area already devoid of
spinal branches or in effect completing the extent of aortic
cover. Staging of type II repairs resulted in a signiﬁcantly
lower overall rate of spinal injury, in addition to all of the
cases of postoperative weakness being transient. As can be
seen in experimental models, performing the most extensive
repairs at different time points allows the collateral network
to reorient itself and to accommodate for the reduction in
blood ﬂow.9 Svensson et al11 have previously described
the reciprocal relationship between neurologic dysfunction
and increased mortality, the enhanced neurologic outcomes
in our staged repair group being equally associated with an
improved mortality. The prior aortic surgery group also
experienced a beneﬁt in this regard, further evidencing
the protective staging-like effect of previous intervention.
The staged group similarly experienced a lower incidence
of respiratory or renal dysfunction, as evidenced by rates
of prolonged intubation and dialysis, respectively; however,
this difference did not reach statistical signiﬁcance, possibly
reﬂective of underpowering.
This concept of staging has been investigated exten-
sively in the cardiothoracic literature as applied to elephant
trunk graft repairs of the thoracic arch.22 Separating what
would be a highly morbid procedure into component pro-
cedures yields a survival beneﬁt, as demonstrated in our se-
ries. Among the criticisms of staging in this realm are the
risks of continued aortic disease in the interval between re-
pairs and the potential for incomplete treatment through
noncompliance or loss to follow-up. This is, of course, a
legitimate concern. Elephant trunk graft staging suffers
particularly in that the most invasive and morbid procedure
is scheduled ﬁrst, from which there needs to be extensive
recovery. Our experience with staging has been excellent.
Thoracic stenting is mostly a low-morbidity operation; no
complications apart from one temporary case of spinal
ischemia occurred in our population. Nonetheless, patients
frequently requested a longer interval between repairs,
resulting in the median of 5 months described in our re-
sults. None were lost to follow-up or declined to return;
however, two patients did rupture while waiting for
completion second stage, as described earlier. The optimal
time interval between stages is unknown but may be as
short as 1 to 2 weeks. Our present interval is determined
by the 6- to 12-week delay in constructing a custom device,
and ultimately this will be addressed by the creation of “off-
the-shelf” designs. Reducing the time between stages will
also limit the risk of rupture in the intervening period.
The present series describes our institutional experience
with this technique since its inception in 2008. Up to that
point, our practice had been to perform all endovascular re-
pairs as a single operation, irrespective of extent. As the suc-
cess of staging in reducing morbidity became manifest, we
tended to use it more frequently, to the extent that almost
all type II repairs are staged at present. Thus, the series
described in this paper is retrospectively accrued and com-
pares cohorts at different but overlapping time points.
Such a temporal difference between groups potentially
JOURNAL OF VASCULAR SURGERY
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situation are minimal as we had performed more than 400
fenestrated repairs alone before the ﬁrst staged procedure
(meaning that technical improvements were unlikely to be
relevant), and the principles of multimodal optimization of
spinal perfusion were fully embedded in out institution by
2008, as described in our previous publication (meaning
that there were no ancillary anesthetic or perioperative mea-
sures instituted that would account for the improvement in
outcome with staged repair).8 A related confounder is that
of selection bias, the more extensive type II repairs being
selected for staging, which is reﬂected in the increased pro-
portion of aorta excluded in the two-stage group. However,
the bias in this case would serve only to heighten the risk
with staging, making the lower spinal ischemia rate associ-
ated with this technique all the more encouraging.
CONCLUSIONS
Staged repair appears both to protect against SCI and
to enhance overall survival in extensive aortic repair.
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at www.jvascsurg.org.DISCUSSIONDr Julie Ann Freischlag (Sacramento, Calif). I have one
initial question. Did you have patients that were scheduled to
have this two stage repair, you did the ﬁrst stage, and for whateverreason they never came back to the second? Did you lose any to
death or other issues between the two stages that were not
included in your review?
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second stage. Two patients suffered a rupture in the intervening
period. One of those patients, unfortunately, expired; and the sec-
ond patient had a successful open repair followed by a successful
fenestrated endovascular aortic aneurysm repair.
Dr Freischlag. Did that change your interval thoughts, or are
you still doing the same amount of time?
Dr O’Callaghan. There is about a 6 to 12 week lag before
we get the fenestrated device designed and ready, so our prac-
tice, when we decide to undertake a staged repair, is to perform
the thoracic endograft as soon as feasible, and in the meantime
we are ordering and constructing the customized fenestrated
device.
Dr William Quinones Baldrich (Los Angeles, Calif). Very
nice presentation and analysis of a large experience. These results
support my impression that staging reduces the risk of paraplegia.
Interval rupture is a well-documented risk. Is there any particular
morphology of the aneurysm that would make you want to repair
it in one stage or reduce the time between stages?
Dr O’Callaghan. Well, clearly, symptomatic patients deserve
an early repair. And as off the shelf devices become more feasible,
then the interval between the staged repairs will again become
shorter.
We know from experimental evidence by Dr Etz’s group that
the time for collateralization is approximately 5 to 7 days. So in
terms of how long we need to leave this, I would say 2 to 3 weeks
may be optimum; but I don’t think anyone knows the exact answer
to that question.
Dr Amy Reed (Hershey, Pa). You touched early on in the pre-
sentation about the length of time for collateralization. You
mentioned 6 to 12 weeks. Could you glean anything from the
data that you had as to the time frame of how long to wait? If
we wait longer, is it better, do patients develop more collateraliza-
tion? That would be assumed.
And then also as far as the extent of where you covered the
thoracic aorta, did you plan to stop at a certain level? Did you al-
ways stop before T10? What was your choice for that?
Dr O’Callaghan. When we implant a thoracic device, we’re
cognizant of leaving enough seal room for the fenestrated compo-
nent and balancing that with the need to cover enough aorta to
stimulate collateralization.
As to the time to collateralization, I don’t think anyone knows
the answer to that question. The numbers are too small and the
times are too heterogeneous to derive any ideal time. I suspect
that the time to collateralization may be much shorter than 6 to
12 weeks. Unfortunately, because of the nature of customized de-
vices, there is a 6 to 12 week lag and that, to an extent, determines
our present time delay.
Dr Thomas Lindsay (Toronto, Ontario, Canada). I’d like to
congratulate the authors as well. I think this is a very seminal piece
of work.
I have a couple of questions:
First of all, we know that when you do a two staged proce-
dure, the ﬁrst surgical stage really doesn’t take very long for the
thoracic piece. What do you think is most important, the inﬂu-
ence of the length of that surgery vs the length of time it takes
to put in a whole device, including the thoracic piece and the
custom?
The second question you didn’t mention is temporary para-
plegia. And as you know, many of these patients have temporary
paraparesis treated with elevating the blood pressure and spinal
cord drainage. And you didn’t touch on the evidence, or the inci-
dence of that, in both of those and maybe you could tell us a little
bit about that.
And then what sort of spinal cord protocol have you been
following for those with temporary paraparesis, and did you see
more in the ﬁrst stage or did you see more in the second stage?
Dr O’Callaghan. We saw one case of temporary paraplegia
following the ﬁrst stage. When we see weakness following the
operation, we endeavor to raise the mean arterial pressure over100 mm Hg, and we try and drop the spinal pressure at 10 or
below to try and alleviate that ischemia.
And in terms then of the paresis, approximately one ﬁfth of the
patients in the single stage group developed permanent paraplegia,
the rest resolved. And all the cases in the two stage group
completely resolved.
And those mirror Dr Eagleton’s publication last year on our
complete experience across our entire population of fenestrated
and branched patients.
Dr Ian Loftus (London, United Kingdom). Just to press on
Tom’s point, was there a difference in spinal drain protection pro-
tocol between those undergoing a single stage and those undergo-
ing the second stage of their staged repair, or are they managed
identically?
Dr O’Callaghan. That was one of the reasons why we chose a
relatively contemporary cohort of patients. In the period we chose,
2008 onwards, there have been no signiﬁcant changes in terms of
our algorithm. All the patients have a spinal drain inserted preop-
eratively. The spinal drain is set at 10 intraoperatively and main-
tained at that point for 2 days; unless the patient develops
ischemia, at which point the spinal drain is lowered and the
mean arterial pressure is raised. And there is absolutely no differ-
ence in terms of how we manage these patients intraoperatively
or postoperatively.
Dr Stephan Haulon (Lille, France). I try to stage as much as
possible also my type II endo repairs. The issue is to ﬁnd a sealing
zone in the middle of the descending thoracic aorta. In most of the
patients, we don’t ﬁnd it because the largest diameter endografts
we have today are 46 mm. Do you think we should design a
new type of endograft just for those two staged procedures?
Dr O’Callaghan. I think when you look into the experi-
mental work on this, these patients need some kind of an ischemic
stress. So designing an endograft that would lead to a threshold of
ischemia without causing complete paralysis seems intuitive. How-
ever, in our experience using commercial devices, we still ﬁnd a
beneﬁt to staging.
Dr Timothy A. Chuter (San Francisco, Calif). I wonder
about the potential for selection bias. How did you select the pa-
tients for the different approaches?
I would also like to comment on the nature of the two stage
procedure whereby you’re hoping for some aneurysm thrombosis,
as a stimulus to collateral formation, but not too much, and you
can’t really predict which it’s going to be. You’re left with two gen-
eral anesthetics, two spinal drain insertions, and all the associated
morbidity without a predictable beneﬁt. Have you considered
the use of a “perfusion-preserving cuff”?
Dr O’Callaghan. Dr Ivancic has published on his perfusion
preservation cuff on a series of 10 patients, and they found three
of those patients developed at least transient ischemia, which is a
rate of 30%. I mean, I think there are many ways to elicit this
stress response and there probably is no ideal method. Certainly,
in our experience, staging makes a lot of sense. To complete a
complete type II endovascular repair, it takes a number of hours,
and so anything that you can do to try and reduce that again
would seem to make intuitive sense, without having direct evi-
dence for it.
In the earlier years, we were staging less patients and per-
forming more of them as a single stage. However, in the last
3 years, most of our type II repairs are staged. So there is a
bias in that respect. But you saw from our results that the
two stage patients have signiﬁcantly more of the aorta covered
by the endovascular device, and therefore they would theoreti-
cally increase risk of spinal cord ischemia. Nonetheless, they
experienced increased survival and reduced overall rates of
ischemia. The perioperative management algorithm has not
changed since 2008.
Have we got everything correct? I don’t think so. We’re still
getting some rates of paresis. I think that probably relates to
your question about how much of the aorta we covered and
what kind of stress response we do elicit. We have no control
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much of the artery we cover in one cohort, we know how much we
can safely cover, I don’t think that question can be answered
correctly.
Dr Jan Blankensteijn (Amsterdam, Netherlands). Just a quick
practical question. Do you use a certain length of coverage as a
threshold to determine in your current practice to stage the proce-
dure, or not?Dr O’Callaghan. No, we have no ﬁxed number. From the
EUROSTAR data, a length of 200 cm would seem to indicate
that that’s one threshold. So again, that might be a number
you have in your head. But overall when we do the staged proce-
dure, we have the overall repair in mind and we are very cogni-
zant of leaving enough thoracic endograft so that we can safely
dock our custom device into it and achieve a durable seal between
devices.
Supplementary Table (online only). Scoring of spinal
cord ischemia (SCI)
Description of function Score
Baseline preoperative function 0
Weakness with antigravity movement preserved 1
Weakness without antigravity movement 2
Complete absence of power 3
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